Colgate-Palmolive Company

NYSE:CL Voorraadrapport

Marktkapitalisatie: US$76.5b

Colgate-Palmolive Toekomstige groei

Future criteriumcontroles 2/6

Colgate-Palmolive zal naar verwachting groeien in winst en omzet met respectievelijk 6.7% en 3.6% per jaar. De winst per aandeel zal naar verwachting groeien met 7.9% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 202.7% zijn.

Belangrijke informatie

6.7%

Groei van de winst

7.9%

Groei van de winst per aandeel

Household Products winstgroei8.2%
Inkomstengroei3.6%
Toekomstig rendement op eigen vermogen202.7%
Dekking van analisten

Good

Laatst bijgewerkt02 Nov 2024

Recente toekomstige groei-updates

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Recent updates

Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price

Nov 20
Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price

If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity

Oct 26
If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity

Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now

Oct 25

Colgate-Palmolive: Very Close To A Buy Following Recent Pullback

Oct 17

Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)

Sep 30

These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well

Sep 11
These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well

Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down

Aug 27
Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Jul 11
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Jul 10

Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite

Jun 23

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Jun 06
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

May 21
Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Colgate-Palmolive: Loading Up Ahead Of Earnings

Apr 16

Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Apr 02
Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 18
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Feb 14
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Colgate-Palmolive: I'm Buying Before Interest Rates Decrease

Feb 14

Colgate-Palmolive: Brushing Up Profits In Q4 2023

Jan 30

Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Jan 19
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Jan 01
Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)

Dec 20

Colgate-Palmolive Stock And Its Real Value

Nov 29

Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On

Nov 14

Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Nov 06
Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Colgate-Palmolive: Own This Dividend King At The Right Price

Oct 31

Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now

Oct 13

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Oct 02
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive: Dividend King With Limited Growth

Sep 27

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Colgate-Palmolive: Improving Prospects And A Reasonable Valuation

Sep 09

Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World

Aug 16

Colgate And The Importance Of Sales Growth, Expectations Matter

Aug 09

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Aug 03
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive: Challenging Growth Prospects

Jul 10

Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Jun 27
Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Jun 13
Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Colgate-Palmolive: The Reasons We Are Becoming More Cautious

Jun 05

Winst- en omzetgroeiprognoses

NYSE:CL - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202621,7253,4333,6844,29115
12/31/202520,8443,1513,4514,03120
12/31/202420,1992,9123,4483,87719
9/30/202420,1062,8683,4003,974N/A
6/30/202419,9892,8403,3583,959N/A
3/31/202419,7522,6113,0233,691N/A
12/31/202319,4572,3003,0403,745N/A
9/30/202319,1361,5872,5533,282N/A
6/30/202318,6761,4972,3563,099N/A
3/31/202318,3381,5982,1682,905N/A
12/31/202217,9671,7851,8602,556N/A
9/30/202217,7411,9282,3212,989N/A
6/30/202217,7001,9442,3843,014N/A
3/31/202217,4762,0442,5313,113N/A
12/31/202117,4212,1662,7583,325N/A
9/30/202117,3422,6652,6473,182N/A
6/30/202117,0812,7292,6623,150N/A
3/31/202116,7182,6613,1143,549N/A
12/31/202016,4712,6953,3093,719N/A
9/30/202016,1622,6913,3683,726N/A
6/30/202015,9372,5713,3303,678N/A
3/31/202015,9062,5222,9503,296N/A
12/31/201915,6932,3672,7983,133N/A
9/30/201915,4892,3302,6843,025N/A
6/30/201915,4062,2752,6423,008N/A
3/31/201915,4262,3262,6563,045N/A
12/31/201815,5442,4002,6203,056N/A
9/30/201815,6252,1172,4612,953N/A
6/30/201815,7542,201N/A3,046N/A
3/31/201815,6942,088N/A2,979N/A
12/31/201715,4542,024N/A3,054N/A
9/30/201715,2832,307N/A3,119N/A
6/30/201715,1762,402N/A3,126N/A
3/31/201715,1952,478N/A3,218N/A
12/31/201615,1952,441N/A3,141N/A
9/30/201615,3732,461N/A3,158N/A
6/30/201615,5052,485N/A3,046N/A
3/31/201615,7262,459N/A2,836N/A
12/31/201516,0342,468N/A2,949N/A
9/30/201516,3562,470N/A3,014N/A
6/30/201516,7362,286N/A3,132N/A
3/31/201517,0222,334N/A3,205N/A
12/31/201417,2772,180N/A3,298N/A
9/30/201417,4172,116N/A3,231N/A
6/30/201417,4362,230N/A3,268N/A
3/31/201417,4302,169N/A3,247N/A
12/31/201317,4202,241N/A3,204N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CL ( 6.7% per jaar) ligt boven de spaarquote ( 2.6% ).

Winst versus markt: De winst van CL ( 6.7% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 15.4% per jaar).

Hoge groeiwinsten: De winst van CL zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van CL ( 3.6% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).

Hoge groei-inkomsten: De omzet van CL ( 3.6% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CL zal naar verwachting over 3 jaar zeer hoog zijn ( 202.7 %).


Ontdek groeibedrijven